Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Synthetic Secretin (ChiRhoStim) vs Triptorelin (Trelstar)
An educational, source-based comparison of Synthetic Secretin (ChiRhoStim) and Triptorelin (Trelstar) — how each peptide works, what it's researched for, and what to know before going deeper.
27-amino-acid peptide used to stimulate pancreatic secretions for diagnosis.
Synthetic human secretin that stimulates pancreatic bicarbonate, fluid secretion, and gastrin release — used diagnostically for pancreatic function, gastrinoma evaluation, and ERCP facilitation.
- Pancreatic function testing
- Gastrinoma (Zollinger-Ellison) diagnosis
- ERCP facilitation
- • FDA-approved.
- • Single diagnostic dose; minimal adverse effects.
Decapeptide GnRH agonist that initially stimulates then desensitizes pituitary GnRH receptors, suppressing LH, FSH, and downstream gonadal steroid production after the initial flare.
- Advanced prostate cancer
- Central precocious puberty (international)
- Endometriosis (international)
- • FDA-approved.
- • Initial testosterone flare; consider antiandrogen pretreatment.
- • Hot flashes, bone density loss with chronic use.
Trial-evidence rating
Educational grade reflecting how many peer-reviewed studies and FDA actions we cite for each peptide. Not a clinical recommendation.
FDA-approved with published clinical trial data.
FDA-approved with published clinical trial data.
Study-by-study comparison
| Peptide | Study | Source | Year | Summary |
|---|---|---|---|---|
| Synthetic Secretin (ChiRhoStim) | Secretin stimulation test for gastrinoma | Gastroenterology | 1989 | Established as gold standard provocative test. |
| Triptorelin (Trelstar) | Triptorelin vs leuprolide in prostate cancer | Urology | 2002 | Comparable testosterone suppression efficacy. |
Side-effect & safety grid
- FDA-approved.
- Single diagnostic dose; minimal adverse effects.
- FDA-approved.
- Initial testosterone flare; consider antiandrogen pretreatment.
- Hot flashes, bone density loss with chronic use.
Educational summary of considerations reported in research literature — not a complete list of adverse events. Discuss with a licensed clinician before any use.
Synthetic Secretin (ChiRhoStim) vs Triptorelin (Trelstar) — Key differences
- Class: Synthetic Secretin (ChiRhoStim) is classified as Diagnostic · Gastroenterology, while Triptorelin (Trelstar) is GnRH Agonist · Oncology.
- Primary research focus: Synthetic Secretin (ChiRhoStim) — pancreatic function testing; Triptorelin (Trelstar) — advanced prostate cancer.
- Tag: FDA-Approved · Diagnostic vs FDA-Approved · Oncology.